slides · global inventory
11 Golden Circle
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,983
Current window 9,601-9,630
Pages 467
Rows per page 30
Loop
9,601-9,630 of 13,983
05
The slide uses a hub-and-spoke layout to surround the product image with key value propositions.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Hyperfine | Investor Presentation Deck | 16 slidesHyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
03
Includes both qualitative business milestones and quantitative financial results/guidance.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
Hyzon | Investor Conference Presentation Deck | 24 slidesHyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
The slide uses a three-row structure to categorize company assets and relationships.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
15
The slide uses a side-by-side comparison of two proprietary platforms.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Immix Biopharma | Investor Presentation Deck | 52 slidesImmix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
17
Includes comparative charts for transduction efficiency and anti-exhaustion capability.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
Includes a comparative table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
42
Includes a table of prevalence/incidence data and a biological pathway diagram.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
43
The slide presents two charts: a tumor volume growth curve over time and a PK/PD profile showing drug concentration and target knockdown over 240 hours.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
44
The slide outlines a standard oncology clinical trial design (3+3 or similar dose escalation) followed by cohort expansion.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
45
Clinical trial safety data presentation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
46
Includes a line chart for PK profiles and a table for PK parameters (Cmax, AUClast, Vd, CL, t1/2).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
47
Includes a line chart showing % change over time and a summary table of patient-level degradation data.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
48
Includes bar charts for SAA/CRP, a longitudinal line chart for SOCS3, and a scatter plot showing correlation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
49
Data cut-off date May 1, 2023. DL1-3 completed, DL4 open.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
03
The slide uses a path metaphor to illustrate the company's unique positioning compared to industry peers.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Loop · Golden Circle1 hit
06
Limbach Holdings | Investor Presentation Deck | 27 slidesLimbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide uses a path metaphor to contrast Limbach's focus on optimization against competitors focused on new construction (changing skylines).Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a checkmark/cross matrix to demonstrate competitive differentiation.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a 2x2 matrix to illustrate a strategic shift from a 'Specialty Contractor' profile to an 'Engineering/OEM' profile.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
03
Mainz Biomed NV | Investor Presentation Deck | 25 slidesMainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
04
Mainz Biomed NV | Investor Presentation Deck | 25 slidesMainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
05
Includes product imagery and regulatory certification (CE-IVD).Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses a linear process diagram to simplify the user experience.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
Uses hub-and-spoke diagrams to visually contrast decentralized vs centralized networks.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide outlines the technical workflow from sample collection to diagnostic output.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
Includes citation for the study published in Clin Lab 10/2018.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
Slide uses a 3-column layout to categorize achievements by strategic pillar.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit